Dolby Laboratories insider plans $2.3M Rule 144 share sale

Dolby Laboratories shareholder plans new stock sale under Rule 144.

Rhea-AI Filing Summary

Dolby Laboratories shareholder plans new stock sale under Rule 144. A filing reports an intention to sell 34,367 shares of Dolby common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $2,305,493.01. Dolby had 60,845,846 shares of common stock outstanding.

The 34,367 shares were acquired on 12/09/2025 via a stock option exercise from the issuer, paid in cash on the same date. Over the past three months, the Yeaman Family Trust has sold additional Dolby common shares in three transactions of 36,699, 25,000, and 25,000 shares, generating gross proceeds of $2,455,401.64, $1,721,840.00, and $1,791,487.50, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing reveal about Dolby (DLB)?

The filing reports a planned sale of 34,367 shares of Dolby Laboratories common stock under Rule 144, with an aggregate market value of $2,305,493.01, to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

How many Dolby (DLB) shares are being reported for sale in this notice?

The notice covers an intended sale of 34,367 shares of Dolby common stock, with an aggregate market value of $2,305,493.01 based on the figures reported.

How were the Dolby (DLB) shares in this Form 144 acquired?

The 34,367 Dolby common shares were acquired on 12/09/2025 via a stock option exercise from the issuer, with the purchase price paid in cash on the same date.

What recent Dolby (DLB) stock sales has the Yeaman Family Trust reported?

Over the prior three months, the Yeaman Family Trust reported three sales of Dolby common stock: 36,699 shares on 11/24/2025 for $2,455,401.64, 25,000 shares on 10/14/2025 for $1,721,840.00, and 25,000 shares on 09/16/2025 for $1,791,487.50.

How many Dolby (DLB) shares were outstanding at the time referenced in the filing?

The filing states that 60,845,846 shares of Dolby common stock were outstanding, providing context for the size of the reported sale.

On which exchange are the Dolby (DLB) shares in this Form 144 expected to be sold?

The shares covered by the notice are expected to be sold on the NYSE, with Morgan Stanley Smith Barney LLC listed as the broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/09/2025 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001200469
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOLBY LABORATORIES, INC.
SEC File Number	001-32431
Address of Issuer	1275 Market Street San Francisco CALIFORNIA 94103-1410
Phone	(415) 558-0200
Name of Person for Whose Account the Securities are To Be Sold	YEAMAN FAMILY TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	34367	2305493.01	60845846	12/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/09/2025	Stock Option Exercise	ISSUER			34367	12/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
YEAMAN FAMILY TRUST 1275 Market Street San Francisco CA 94103-1410	Common	11/24/2025	36699	2455401.64
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	10/14/2025	25000	1721840.00
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	09/16/2025	25000	1791487.50

144: Remarks and Signature

Remarks
Date of Notice	12/09/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kevin John Yeaman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)